Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Lam, Carolyn S
  • Branch, Kelley R
  • Sattar, Naveed
  • Rosenstock, Julio
  • Pratley, Richard
  • del Prato, Stefano
  • Lopes, Renato D
  • Niemoeller, Elisabeth
  • Khurmi, Nardev S
  • Baek, Seungjae
  • Gerstein, Hertzel Chaim

publication date

  • December 21, 2021